Monthly Archives: June 2017

Finding The Right Treatment For MS

Dr. Shiva Gopal Vashishta is an individual who practice psychiatry and neurology. Dr. Shiva Gopal Vashishta is an individual who is highly recognized in the Voorhees New Jersey area because he is a doctor who is dedicated to helping those individuals who suffer from multiple sclerosis. Dr. Shiva Gopal Vashishta practices neurology at the Eastern Neurodiagnostic Associates. This is a clinic that is associated with the Kennedy Health System Cherry Hill Campus. Dr. Shiva Gopal Vashishta graduated from medical College in 1979, and he received his residency at Boston City Hill Hospital.


Dr. Shiva Gopal Vashishta is an individual who has dedicated his life to helping individuals who suffer from serious neurological problems. Dr. Shiva Gopal Vashishta is board-certified, and he takes many different insurance plans. Dr. Shiva Gopal Vashishta is an individual who has been practicing neurology for over 40 years, and he also is a psychiatrist. recently did an article about how a large amount of patients are receiving help for their multiple sclerosis symptoms by using stem cell transplants. This is a five-year test that has given promising results. Multiple sclerosis is an autoimmune disease that attacks the central nervous system. This unique type of therapy uses a person’s own stem cells, and it can help those individuals who are suffering from MS. The trial that was conducted on these individuals between the ages of 26 to 52, and it showed that 60% of those who received this therapy did not have any relapses of symptoms or new brain lesions. This information is truly remarkable because this evidence proves that this form of therapy is more effective than the majority of long-term medications that many multiple sclerosis patients are taking.


The different symptoms are associated with multiple sclerosis can be varied and they include the following: weakness, fatigue, speech problems and intense pain. This experimental stem cell treatment uses the patient’s own blood forming cells and gives them high-doses of chemotherapy to rebuild their own immune system. There is more investigation that needs to be done on this therapy, but the current results are very promising.


Goettl Hopes Everybody Enjoys A Cool Summer

Enjoying the Summer months can be difficult for those who are struggling to keep their to keep their home or business cool and comfortable even when the heat rises to the extremes seen across the southwest of the U.S. The Goettl company of HVAC technicians is hoping to provide a few simple tips and pieces of advice to help everybody cool their homes and lower their utility bills in a few simple to understand ways.

Among the many tips provided in the “Goettl Tells All” article the Arizona and Nevada based HVAC company explains it is important to make sure the building is prepared to keep the cooled air within the parcel of the property. Making sure all cracks and gaps are sealed is the first step to creating a cool and comfortable home with the installation of new insulation always a good way of making sure cool air stays within the property. As an HVAC company, Goettl also wants everybody to make sure they are exploring the needs of their system with a maintenance needs handled by a professional company.

The Goettl brand has been at the forefront of the HVAC industry since its inception in the 1930s and is known as one of the leaders in providing innovations for its customers; although many of the innovations are now in the technology being installed, the Goettl company developed many of the pieces of technology still used to cool homes across the world.

In 2014, Ken Goodrich became the owner of Goettl and made the decision to work with the HVAC program at the College of Southern Nevada to help train the next generation of Goettl technicians. A series of scholarships and sponsorship programs have been developed at the College Of Southern Nevada to make sure Goettl is involved in the training of its next generation of technicians.

Meet Jose Henrique Borghi, a Top Player in the Advertising World

Brazil has the best advertising agencies across the globe with ads campaigns used by Honda, Mitsubishi, American Express, and Unilever originating from Brazil. There are several individuals responsible for creating these advertisements that many relate to and love. One such person is Jose Henrique Borghi who has made a name for himself in the ad market such that many associates that name to creativity in the ads and marketing world. For instance, Mr. Borghi was behind the creation of ad campaigns for top companies including Ikea, Google, Western Union, Hyatt, Johnson & Johnson, Mattel, JetBlue, General Motors, Harley Davidson and Royal Caribbean among others.

Jose Henrique has over two decades in the advertising industry. Shortly after finishing his studies, Jose started off his profession working as an advertising agent for Ogilvy ad Academy in 1988. Later on, he joined other ad firms including Talent and DM9DDB. In 1999, Mr. Borghi career advanced when he was appointed the Chief Creative Officer at Leo Burnett where he worked diligently and got the top CEO position in the company until 2002.

He left Leo Burnett and partnered with Ray Erh and together they started BorgiErh adversity agency which later merged with Lowe+ Partners. In 2015, the Mullen Group purchased the company, and it became Mullen Lowe Brasil with Jose as it CEO, a position he still holds to date. Under Jose’s leadership and capable hands, Mullen Ad Agency has to continue to excel in many advertisements with greater coverage outside the Brazilian borders.

In its efforts to expand, the agency made another merger becoming Borghi/Lowe Agency in Brazil with Jose as its co-CEO with Andre Gomes. Mr. Borghi’s duties at the firm include administration of social media platforms, design planning mobile and digital marketing, performance analytics and public relations. Moreover, Jose Henrique has won several awards at key Brazilian and global events including being named the Advertising Professional of the year by the Brazilian Advertising Association (ABP) in 2014.


A Shark in the Waters – Marketing With White Shark Media

Small to medium sized businesses looking for online marketing solutions often turn to the Digital Marketing Agency, White Shark Media. Companies using this agency see significant growth due to White Shark Media’s marketing tools and expertise.

White Shark Media prides themselves on tracking their clients’ marketing efforts in detail. They always make themselves fully accountable to their clients, and they use tools such as keyword-level call tracking, Google Analytics integration and competitive intelligence and proprietary reporting software.

The company employs over 150 people and has a close relationship with Google. They offer cost effective marketing solutions, and they understand that client satisfaction is the most important aspect of building a strong, growing company. CEO Alexander Nygart plans to develop more relationships with companies in the coming years and bring aboard many more employees who can positively contribute to White Shark Media’s success.

The employees at White Shark Media are known for carefully listening to the needs of their clients and acting accordingly. They respond to questions and concerns in a timely manner and always keep the client fully aware of each step in the marketing campaign. Their clients speak highly of their marketing efforts and the positive effects that White Shark Media has had on all of the companies that they work with. They have improved clients website traffic, and have had positive impacts on lead generation.

Flexible and professional, the employees at White Shark are easy to communicate with, and will tailor a marketing campaign that is in the clients best interest. Expect great results with White Shark Media!

Dr. Clay Siegall on Targeted Cancer Therapies

Dr. Clay Siegall has become a known figure in cancer treatment since founding his biotech firm Seattle Genetics, working with top researchers that develop targeted drug and therapy courses in an effort to improve these fields of research. Seattle Genetics started small but soon became an influential player in cancer research, and Dr. Clay Siegall intends for his firm to increase its standing as an authority in this field by better understanding how to tailor treatment for individual patients.


Dr. Siegall’s interest in medicine and technology guided his studies at the University of Maryland, and when a family member became ill he noted the changes in their health attributed to chemotherapy. This led him to consider alternatives to treatment.


Seattle Genetics is funded primary through sales of medication, and their currently awaiting FDA approval to put more into the market. Partnerships and licensing also helps by continuing to promote the Seattle Genetics brand while bringing in the funding necessary to deal with the expensive process of getting drugs approved by the FDA. But in the early days, Dr. Siegall relied on negotiating with and attracting investors. It was instrumental in getting the firm off the ground.


Moving forward, Dr. Siegall sees a bright future for Seattle Genetics. The hard work that has made his firm come this far, Dr. Siegall sees as an integral character trait of everyone working in this field.


About Dr. Clay Siegall:


Dr. Clay Siegall is an American geneticist and founder and CEO of Seattle Genetics. After receiving his Ph.D. in Genetics from George Washington University. Dr. Siegall served as a member of the National Cancer Institute and the National Institutes of Health between 1988 and 1991 before going on to join Bristol-Myers Squibb Pharmaceutical Research Institute until 1997.


In 1998, Dr. Siegall co-founded Seattle Genetics, a biomedical firm that focuses on researching and developing cancer treatment alternatives to chemotherapy where he serves as President, Chief Executive Officer, and Chairman of the Board of Directors. As an authority in the field, Dr. Siegall has been instrumental in raising investment in the company and has secured more than $675 million in public and private funds. In 2011 their antibody medication ADCETRIS was granted accelerated approval by the FDA.